🔗 Permalink

Assignee profile:

Action Medicines

City:

Madrid

Country:

Spain

Published Applications:

Last publication date:

2012-06-07

Patent Grants:

Last grant date:

2013-05-07

Top Inventors for applications by Action Medicines

These are the the leading inventors for applications assigned to Action Medicines:

Rosa Maria Lozano Puerto 13 Madrid, Spain
Antonio Romero Garrido 13 Madrid, Spain
Pedro Cuevas Sànchez 13 Madrid, Spain
Guillermo Gimenez Gallego 13 Madrid, Spain

Serafin Valverde Lopez 13 Madrid, Spain
Javier Angulo Frutos 10 Madrid, Spain
Inigo Saenz de Tejada Morgan 8 Madrid, Spain
Inigo Saenz de Tejada Gorman 4 Madrid, Spain

Javier Angulo Frutos 2 Valdermo, Spain
Atonio Romero Garrido 1 Madrid, Spain
Francisco Javier Moreno Nuncio 1 Madrid, Spain
Antonio Romero Garrido 1 Collado Villalba, Spain

Pedro Cuevas S?nchez 1 Madrid, Spain
Tomas Fernado Fernandez Jaen 1 Madrid, Spain
Maria Luisa Krauel 1 Madrid, Spain
Luis Ignacio Rivas López 1 Madrid, Spain

Serafin Vaverde Lopez 1 Madrid, Spain
Pedro Cuevas Sánchez 1 Madred, Spain

Recent patent applications by Action Medicines

Action Medicines based in Madrid, ES has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-06-07 ✅ Patent 8,435,971 granted on 2013-05-07

US20120142780A1

Human necessities

Use of 2,5-dihydroxybenzenesulfonic acid in the manufacturing of medicines, applicable to the treatment of angiodependent diseases

#2 | 2012-03-29

US20120077785A1

Human necessities

METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS

#3 | 2012-01-19 ✅ Patent 9,198,886 granted on 2015-12-01

US20120015912A1

Human necessities

Use of 2,5-dihydroxybenzene for the treatment of ocular diseases

#4 | 2011-12-22 ✅ Patent 8,530,454 granted on 2013-09-10

US20110311528A1

Human necessities

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis

#5 | 2011-10-20 ✅ Patent 8,436,045 granted on 2013-05-07

US20110257264A1

Human necessities

Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis

#6 | 2011-09-29 ✅ Patent 8,492,367 granted on 2013-07-23

US20110237555A1

Human necessities

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#7 | 2008-05-29 ✅ Patent 8,541,467 granted on 2013-09-24

US20080125486A1

Human necessities

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

#8 | 2008-05-29

US20080125485A1

Human necessities

Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis

#9 | 2008-05-15

US20080114075A1

Human necessities

Use of 2,5-Dihydroxybenzene Derivatives for Treating Dermatitis

#10 | 2008-05-15

US20080114063A1

Human necessities

Use of 2,5-Dihydroxybenzene Derivatives for the Treatment of Tissue Reactive Diseases

#11 | 2008-05-15 ✅ Patent 8,101,660 granted on 2012-01-24

US20080114060A1

Human necessities

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#12 | 2008-05-15

US20080113948A1

Human necessities

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis

#13 | 2008-05-15

US20080113947A1

Human necessities

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea

AssigneeID:

174520 ⎘